Tom70 Serves as a Molecular Switch to Determine Pathological Cardiac Hypertrophy

Cell Research - United States
doi 10.1038/cr.2014.94
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tripartite Motif 32 Prevents Pathological Cardiac Hypertrophy

Clinical Science
Medicine
2016English

Nuclear GAPDH Signaling Mediates Pathological Cardiac Hypertrophy

2019English

Fibronectin Contributes to Pathological Cardiac Hypertrophy but Not Physiological Growth

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Mechanisms for the Transition From Physiological to Pathological Cardiac Hypertrophy

Canadian Journal of Physiology and Pharmacology
MedicinePhysiologyPharmacology
2020English

A Solid-State Protein Junction Serves as a Bias-Induced Current Switch

Angewandte Chemie - International Edition
CatalysisChemistry
2019English

Increased Afterload Induces Pathological Cardiac Hypertrophy: A New in Vitro Model

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2012English

The Transcription Factor GATA-6 Regulates Pathological Cardiac Hypertrophy

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

The H3K9 Dimethyltransferases EHMT1/2 Protect Against Pathological Cardiac Hypertrophy

Journal of Clinical Investigation
Medicine
2016English

Reversal of Pathological Cardiac Hypertrophy via the MEF2-coregulator Interface

JCI insight
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy